Skip to main
SLP

Simulations Plus (SLP) Stock Forecast & Price Target

Simulations Plus (SLP) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Simulations Plus Inc. demonstrated a robust performance in Q3, with the dollar value of awarded work not yet recognized increasing by approximately 30% year-over-year, indicating strong demand for its services. The software segment, which generates the majority of the company's revenue, achieved a notable 22% year-over-year increase in revenue, correlated with a positive shift in biotech funding and proposal activity from clients. This momentum is further supported by improved RFP flow and confidence among global biopharmaceutical clients, suggesting a favorable outlook for the company’s growth trajectory in the pharmaceutical research and education market.

Bears say

Simulations Plus Inc. reported a -6% year-over-year decline in total revenue for F4Q:25, despite showing a +13% increase for the full-year, indicating volatility and inconsistency in revenue generation. The company's guidance for F1Q:26 suggests an anticipated further decline of -3% to -5%, and its projected revenue growth of only +0-4% for F26 appears underwhelming compared to peers in the pharmaceutical technology and health-tech sectors. Additionally, the decrease in revenue from key segments, including a notable loss of a large client in the CDMO business, raises concerns about the company's long-term growth trajectory and market competitiveness.

Simulations Plus (SLP) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Simulations Plus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Simulations Plus (SLP) Forecast

Analysts have given Simulations Plus (SLP) a Buy based on their latest research and market trends.

According to 5 analysts, Simulations Plus (SLP) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Simulations Plus (SLP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.